English
简体中文
Total: £ 56.28
Published Date: 2026-03-27 | Pages: 114 | Tables: 116 | Medical Devices & Consumables
The global Vaccines For Cattle And Sheep market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Vaccines For Cattle And Sheep competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Vaccines For Cattle And Sheep is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Vaccines For Cattle And Sheep is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Vaccines For Cattle And Sheep include Merck Animal Health USA, AHDB, MSD Animal Health HUB, Ceva South Africa, Virbac Australia, Valley Vet Supply, Angelo Pellets, Inc., PBS Animal Health, A to Z Vet Supply, EntirelyPets, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Vaccines For Cattle And Sheep market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Vaccines For Cattle And Sheep. The Vaccines For Cattle And Sheep market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Vaccines For Cattle And Sheep market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Vaccines For Cattle And Sheep manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Merck Animal Health USA
AHDB
MSD Animal Health HUB
Ceva South Africa
Virbac Australia
Valley Vet Supply
Angelo Pellets, Inc.
PBS Animal Health
A to Z Vet Supply
EntirelyPets
Segment by Type
Bacterial Disease Vaccine
Virus Vaccine
Mixed Vaccine
by Application
Dairy Cow
Beef Cattle
Sheep
Goat
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Vaccines For Cattle And Sheep manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Vaccines For Cattle And Sheep sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Vaccines For Cattle And Sheep Market Overview
1.1 Product Definition
1.2 Vaccines For Cattle And Sheep by Type
1.2.1 Global Vaccines For Cattle And Sheep Market Value by Type: 2025 vs 2032
1.2.2 Bacterial Disease Vaccine
1.2.3 Virus Vaccine
1.2.4 Mixed Vaccine
1.3 Vaccines For Cattle And Sheep by Application
1.3.1 Global Vaccines For Cattle And Sheep Market Value by Application: 2025 vs 2032
1.3.2 Dairy Cow
1.3.3 Beef Cattle
1.3.4 Sheep
1.3.5 Goat
1.3.6 Other
1.4 Global Vaccines For Cattle And Sheep Market Size Estimates and Forecasts
1.4.1 Global Vaccines For Cattle And Sheep Revenue 2021–2032
1.4.2 Global Vaccines For Cattle And Sheep Sales 2021–2032
1.4.3 Global Vaccines For Cattle And Sheep Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Vaccines For Cattle And Sheep Market Competition by Manufacturers
2.1 Global Vaccines For Cattle And Sheep Sales Market Share by Manufacturers (2021–2026)
2.2 Global Vaccines For Cattle And Sheep Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Vaccines For Cattle And Sheep Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Vaccines For Cattle And Sheep, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Vaccines For Cattle And Sheep, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Vaccines For Cattle And Sheep, Product Types and Applications
2.7 Global Key Manufacturers of Vaccines For Cattle And Sheep, Date of Entry into the Industry
2.8 Global Vaccines For Cattle And Sheep Market Competitive Situation and Trends
2.8.1 Global Vaccines For Cattle And Sheep Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Vaccines For Cattle And Sheep Players Market Share by Revenue
2.8.3 Global Vaccines For Cattle And Sheep Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccines For Cattle And Sheep Market Scenario by Region
3.1 Global Vaccines For Cattle And Sheep Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Vaccines For Cattle And Sheep Sales by Region: 2021–2032
3.2.1 Global Vaccines For Cattle And Sheep Sales by Region: 2021–2026
3.2.2 Global Vaccines For Cattle And Sheep Sales by Region: 2027–2032
3.3 Global Vaccines For Cattle And Sheep Revenue by Region: 2021–2032
3.3.1 Global Vaccines For Cattle And Sheep Revenue by Region: 2021–2026
3.3.2 Global Vaccines For Cattle And Sheep Revenue by Region: 2027–2032
3.4 North America Vaccines For Cattle And Sheep Market Facts & Figures by Country
3.4.1 North America Vaccines For Cattle And Sheep Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Vaccines For Cattle And Sheep Sales by Country (2021–2032)
3.4.3 North America Vaccines For Cattle And Sheep Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vaccines For Cattle And Sheep Market Facts & Figures by Country
3.5.1 Europe Vaccines For Cattle And Sheep Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Vaccines For Cattle And Sheep Sales by Country (2021–2032)
3.5.3 Europe Vaccines For Cattle And Sheep Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines For Cattle And Sheep Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccines For Cattle And Sheep Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Vaccines For Cattle And Sheep Sales by Region (2021–2032)
3.6.3 Asia Pacific Vaccines For Cattle And Sheep Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Vaccines For Cattle And Sheep Market Facts & Figures by Country
3.7.1 Latin America Vaccines For Cattle And Sheep Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Vaccines For Cattle And Sheep Sales by Country (2021–2032)
3.7.3 Latin America Vaccines For Cattle And Sheep Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Vaccines For Cattle And Sheep Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines For Cattle And Sheep Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Vaccines For Cattle And Sheep Sales by Country (2021–2032)
3.8.3 Middle East and Africa Vaccines For Cattle And Sheep Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines For Cattle And Sheep Sales by Type (2021–2032)
4.1.1 Global Vaccines For Cattle And Sheep Sales by Type (2021–2026)
4.1.2 Global Vaccines For Cattle And Sheep Sales by Type (2027–2032)
4.1.3 Global Vaccines For Cattle And Sheep Sales Market Share by Type (2021–2032)
4.2 Global Vaccines For Cattle And Sheep Revenue by Type (2021–2032)
4.2.1 Global Vaccines For Cattle And Sheep Revenue by Type (2021–2026)
4.2.2 Global Vaccines For Cattle And Sheep Revenue by Type (2027–2032)
4.2.3 Global Vaccines For Cattle And Sheep Revenue Market Share by Type (2021–2032)
4.3 Global Vaccines For Cattle And Sheep Price by Type (2021–2032)
5 Segment by Application
5.1 Global Vaccines For Cattle And Sheep Sales by Application (2021–2032)
5.1.1 Global Vaccines For Cattle And Sheep Sales by Application (2021–2026)
5.1.2 Global Vaccines For Cattle And Sheep Sales by Application (2027–2032)
5.1.3 Global Vaccines For Cattle And Sheep Sales Market Share by Application (2021–2032)
5.2 Global Vaccines For Cattle And Sheep Revenue by Application (2021–2032)
5.2.1 Global Vaccines For Cattle And Sheep Revenue by Application (2021–2026)
5.2.2 Global Vaccines For Cattle And Sheep Revenue by Application (2027–2032)
5.2.3 Global Vaccines For Cattle And Sheep Revenue Market Share by Application (2021–2032)
5.3 Global Vaccines For Cattle And Sheep Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck Animal Health USA
6.1.1 Merck Animal Health USA Company Information
6.1.2 Merck Animal Health USA Description and Business Overview
6.1.3 Merck Animal Health USA Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Animal Health USA Vaccines For Cattle And Sheep Product Portfolio
6.1.5 Merck Animal Health USA Recent Developments/Updates
6.2 AHDB
6.2.1 AHDB Company Information
6.2.2 AHDB Description and Business Overview
6.2.3 AHDB Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AHDB Vaccines For Cattle And Sheep Product Portfolio
6.2.5 AHDB Recent Developments/Updates
6.3 MSD Animal Health HUB
6.3.1 MSD Animal Health HUB Company Information
6.3.2 MSD Animal Health HUB Description and Business Overview
6.3.3 MSD Animal Health HUB Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 MSD Animal Health HUB Vaccines For Cattle And Sheep Product Portfolio
6.3.5 MSD Animal Health HUB Recent Developments/Updates
6.4 Ceva South Africa
6.4.1 Ceva South Africa Company Information
6.4.2 Ceva South Africa Description and Business Overview
6.4.3 Ceva South Africa Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ceva South Africa Vaccines For Cattle And Sheep Product Portfolio
6.4.5 Ceva South Africa Recent Developments/Updates
6.5 Virbac Australia
6.5.1 Virbac Australia Company Information
6.5.2 Virbac Australia Description and Business Overview
6.5.3 Virbac Australia Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Virbac Australia Vaccines For Cattle And Sheep Product Portfolio
6.5.5 Virbac Australia Recent Developments/Updates
6.6 Valley Vet Supply
6.6.1 Valley Vet Supply Company Information
6.6.2 Valley Vet Supply Description and Business Overview
6.6.3 Valley Vet Supply Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Valley Vet Supply Vaccines For Cattle And Sheep Product Portfolio
6.6.5 Valley Vet Supply Recent Developments/Updates
6.7 Angelo Pellets, Inc.
6.7.1 Angelo Pellets, Inc. Company Information
6.7.2 Angelo Pellets, Inc. Description and Business Overview
6.7.3 Angelo Pellets, Inc. Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Angelo Pellets, Inc. Vaccines For Cattle And Sheep Product Portfolio
6.7.5 Angelo Pellets, Inc. Recent Developments/Updates
6.8 PBS Animal Health
6.8.1 PBS Animal Health Company Information
6.8.2 PBS Animal Health Description and Business Overview
6.8.3 PBS Animal Health Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 PBS Animal Health Vaccines For Cattle And Sheep Product Portfolio
6.8.5 PBS Animal Health Recent Developments/Updates
6.9 A to Z Vet Supply
6.9.1 A to Z Vet Supply Company Information
6.9.2 A to Z Vet Supply Description and Business Overview
6.9.3 A to Z Vet Supply Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 A to Z Vet Supply Vaccines For Cattle And Sheep Product Portfolio
6.9.5 A to Z Vet Supply Recent Developments/Updates
6.10 EntirelyPets
6.10.1 EntirelyPets Company Information
6.10.2 EntirelyPets Description and Business Overview
6.10.3 EntirelyPets Vaccines For Cattle And Sheep Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 EntirelyPets Vaccines For Cattle And Sheep Product Portfolio
6.10.5 EntirelyPets Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines For Cattle And Sheep Industry Chain Analysis
7.2 Vaccines For Cattle And Sheep Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines For Cattle And Sheep Production Mode & Process Analysis
7.4 Vaccines For Cattle And Sheep Sales and Marketing
7.4.1 Vaccines For Cattle And Sheep Sales Channels
7.4.2 Vaccines For Cattle And Sheep Distributors
7.5 Vaccines For Cattle And Sheep Customer Analysis
8 Vaccines For Cattle And Sheep Market Dynamics
8.1 Vaccines For Cattle And Sheep Industry Trends
8.2 Vaccines For Cattle And Sheep Market Drivers
8.3 Vaccines For Cattle And Sheep Market Challenges
8.4 Vaccines For Cattle And Sheep Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Vaccines For Cattle And Sheep Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Vaccines For Cattle And Sheep Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Vaccines For Cattle And Sheep Market Competitive Situation by Manufacturers in 2025
Table 4. Global Vaccines For Cattle And Sheep Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Vaccines For Cattle And Sheep Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Vaccines For Cattle And Sheep Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Vaccines For Cattle And Sheep Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Vaccines For Cattle And Sheep Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Vaccines For Cattle And Sheep, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Vaccines For Cattle And Sheep, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Vaccines For Cattle And Sheep, Product Types and Applications
Table 12. Global Key Manufacturers of Vaccines For Cattle And Sheep, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccines For Cattle And Sheep Companies by Tier (Tier 1, Tier 2, Tier 3), based on Vaccines For Cattle And Sheep Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccines For Cattle And Sheep Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Vaccines For Cattle And Sheep Sales by Region (K Units), 2021–2026
Table 18. Global Vaccines For Cattle And Sheep Sales Market Share by Region (2021–2026)
Table 19. Global Vaccines For Cattle And Sheep Sales by Region (K Units), 2027–2032
Table 20. Global Vaccines For Cattle And Sheep Sales Market Share by Region (2027–2032)
Table 21. Global Vaccines For Cattle And Sheep Revenue by Region (US$ Million), 2021–2026
Table 22. Global Vaccines For Cattle And Sheep Revenue Market Share by Region (2021–2026)
Table 23. Global Vaccines For Cattle And Sheep Revenue by Region (US$ Million), 2027–2032
Table 24. Global Vaccines For Cattle And Sheep Revenue Market Share by Region (2027–2032)
Table 25. North America Vaccines For Cattle And Sheep Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Vaccines For Cattle And Sheep Sales by Country (K Units), 2021–2026
Table 27. North America Vaccines For Cattle And Sheep Sales by Country (K Units), 2027–2032
Table 28. North America Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2021–2026
Table 29. North America Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Vaccines For Cattle And Sheep Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Vaccines For Cattle And Sheep Sales by Country (K Units), 2021–2026
Table 32. Europe Vaccines For Cattle And Sheep Sales by Country (K Units), 2027–2032
Table 33. Europe Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Vaccines For Cattle And Sheep Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Vaccines For Cattle And Sheep Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Vaccines For Cattle And Sheep Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Vaccines For Cattle And Sheep Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Vaccines For Cattle And Sheep Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Vaccines For Cattle And Sheep Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Vaccines For Cattle And Sheep Sales by Country (K Units), 2021–2026
Table 42. Latin America Vaccines For Cattle And Sheep Sales by Country (K Units), 2027–2032
Table 43. Latin America Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Vaccines For Cattle And Sheep Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Vaccines For Cattle And Sheep Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Vaccines For Cattle And Sheep Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Vaccines For Cattle And Sheep Revenue by Country (US$ Million), 2027–2032
Table 50. Global Vaccines For Cattle And Sheep Sales (K Units) by Type (2021–2026)
Table 51. Global Vaccines For Cattle And Sheep Sales (K Units) by Type (2027–2032)
Table 52. Global Vaccines For Cattle And Sheep Sales Market Share by Type (2021–2026)
Table 53. Global Vaccines For Cattle And Sheep Sales Market Share by Type (2027–2032)
Table 54. Global Vaccines For Cattle And Sheep Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Vaccines For Cattle And Sheep Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Vaccines For Cattle And Sheep Revenue Market Share by Type (2021–2026)
Table 57. Global Vaccines For Cattle And Sheep Revenue Market Share by Type (2027–2032)
Table 58. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Type (2021–2026)
Table 59. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Type (2027–2032)
Table 60. Global Vaccines For Cattle And Sheep Sales (K Units) by Application (2021–2026)
Table 61. Global Vaccines For Cattle And Sheep Sales (K Units) by Application (2027–2032)
Table 62. Global Vaccines For Cattle And Sheep Sales Market Share by Application (2021–2026)
Table 63. Global Vaccines For Cattle And Sheep Sales Market Share by Application (2027–2032)
Table 64. Global Vaccines For Cattle And Sheep Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Vaccines For Cattle And Sheep Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Vaccines For Cattle And Sheep Revenue Market Share by Application (2021–2026)
Table 67. Global Vaccines For Cattle And Sheep Revenue Market Share by Application (2027–2032)
Table 68. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Application (2021–2026)
Table 69. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Application (2027–2032)
Table 70. Merck Animal Health USA Company Information
Table 71. Merck Animal Health USA Description and Business Overview
Table 72. Merck Animal Health USA Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Merck Animal Health USA Vaccines For Cattle And Sheep Product
Table 74. Merck Animal Health USA Recent Developments/Updates
Table 75. AHDB Company Information
Table 76. AHDB Description and Business Overview
Table 77. AHDB Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AHDB Vaccines For Cattle And Sheep Product
Table 79. AHDB Recent Developments/Updates
Table 80. MSD Animal Health HUB Company Information
Table 81. MSD Animal Health HUB Description and Business Overview
Table 82. MSD Animal Health HUB Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. MSD Animal Health HUB Vaccines For Cattle And Sheep Product
Table 84. MSD Animal Health HUB Recent Developments/Updates
Table 85. Ceva South Africa Company Information
Table 86. Ceva South Africa Description and Business Overview
Table 87. Ceva South Africa Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Ceva South Africa Vaccines For Cattle And Sheep Product
Table 89. Ceva South Africa Recent Developments/Updates
Table 90. Virbac Australia Company Information
Table 91. Virbac Australia Description and Business Overview
Table 92. Virbac Australia Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Virbac Australia Vaccines For Cattle And Sheep Product
Table 94. Virbac Australia Recent Developments/Updates
Table 95. Valley Vet Supply Company Information
Table 96. Valley Vet Supply Description and Business Overview
Table 97. Valley Vet Supply Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Valley Vet Supply Vaccines For Cattle And Sheep Product
Table 99. Valley Vet Supply Recent Developments/Updates
Table 100. Angelo Pellets, Inc. Company Information
Table 101. Angelo Pellets, Inc. Description and Business Overview
Table 102. Angelo Pellets, Inc. Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Angelo Pellets, Inc. Vaccines For Cattle And Sheep Product
Table 104. Angelo Pellets, Inc. Recent Developments/Updates
Table 105. PBS Animal Health Company Information
Table 106. PBS Animal Health Description and Business Overview
Table 107. PBS Animal Health Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. PBS Animal Health Vaccines For Cattle And Sheep Product
Table 109. PBS Animal Health Recent Developments/Updates
Table 110. A to Z Vet Supply Company Information
Table 111. A to Z Vet Supply Description and Business Overview
Table 112. A to Z Vet Supply Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. A to Z Vet Supply Vaccines For Cattle And Sheep Product
Table 114. A to Z Vet Supply Recent Developments/Updates
Table 115. EntirelyPets Company Information
Table 116. EntirelyPets Description and Business Overview
Table 117. EntirelyPets Vaccines For Cattle And Sheep Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. EntirelyPets Vaccines For Cattle And Sheep Product
Table 119. EntirelyPets Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Vaccines For Cattle And Sheep Distributors List
Table 123. Vaccines For Cattle And Sheep Customers List
Table 124. Vaccines For Cattle And Sheep Market Trends
Table 125. Vaccines For Cattle And Sheep Market Drivers
Table 126. Vaccines For Cattle And Sheep Market Challenges
Table 127. Vaccines For Cattle And Sheep Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccines For Cattle And Sheep
Figure 2. Global Vaccines For Cattle And Sheep Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Vaccines For Cattle And Sheep Market Share by Type: 2025 & 2032
Figure 4. Bacterial Disease Vaccine Product Picture
Figure 5. Virus Vaccine Product Picture
Figure 6. Mixed Vaccine Product Picture
Figure 7. Global Vaccines For Cattle And Sheep Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Vaccines For Cattle And Sheep Market Share by Application: 2025 & 2032
Figure 9. Dairy Cow
Figure 10. Beef Cattle
Figure 11. Sheep
Figure 12. Goat
Figure 13. Other
Figure 14. Global Vaccines For Cattle And Sheep Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Vaccines For Cattle And Sheep Market Size (US$ Million), 2021–2032
Figure 16. Global Vaccines For Cattle And Sheep Sales (K Units), 2021–2032
Figure 17. Global Vaccines For Cattle And Sheep Average Price (US$/Unit), 2021–2032
Figure 18. Vaccines For Cattle And Sheep Report Years Considered
Figure 19. Vaccines For Cattle And Sheep Sales Share by Manufacturers in 2025
Figure 20. Global Vaccines For Cattle And Sheep Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Vaccines For Cattle And Sheep Players: Market Share by Revenue in Vaccines For Cattle And Sheep in 2025
Figure 22. Vaccines For Cattle And Sheep Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Vaccines For Cattle And Sheep Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Vaccines For Cattle And Sheep Sales Market Share by Country (2021–2032)
Figure 25. North America Vaccines For Cattle And Sheep Revenue Market Share by Country (2021–2032)
Figure 26. United States Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Vaccines For Cattle And Sheep Sales Market Share by Country (2021–2032)
Figure 29. Europe Vaccines For Cattle And Sheep Revenue Market Share by Country (2021–2032)
Figure 30. Germany Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Vaccines For Cattle And Sheep Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Vaccines For Cattle And Sheep Revenue Market Share by Region (2021–2032)
Figure 37. China Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Vaccines For Cattle And Sheep Sales Market Share by Country (2021–2032)
Figure 45. Latin America Vaccines For Cattle And Sheep Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Vaccines For Cattle And Sheep Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Vaccines For Cattle And Sheep Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Vaccines For Cattle And Sheep Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Vaccines For Cattle And Sheep by Type (2021–2032)
Figure 56. Global Revenue Market Share of Vaccines For Cattle And Sheep by Type (2021–2032)
Figure 57. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Vaccines For Cattle And Sheep by Application (2021–2032)
Figure 59. Global Revenue Market Share of Vaccines For Cattle And Sheep by Application (2021–2032)
Figure 60. Global Vaccines For Cattle And Sheep Price (US$/Unit) by Application (2021–2032)
Figure 61. Vaccines For Cattle And Sheep Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
